Literature DB >> 25298247

An explosive outbreak of Streptococcus pneumoniae serotype-8 infection in a highly vaccinated residential care home, England, summer 2012.

H L Thomas1, R Gajraj2, M P E Slack3, C Sheppard3, P Hawkey4, S Gossain4, C M Drew2, R G Pebody1.   

Abstract

In August 2012, an explosive outbreak of severe lower respiratory tract infection (LRTI) due to Streptococcus pneumoniae serotype-8 occurred in a highly vaccinated elderly institutionalized population in England. Fifteen of 23 residents developed LRTI over 4 days (attack rate 65%); 11 had confirmed S. pneumoniae serotype-8 disease, and two died. Following amoxicillin chemoprophylaxis and pneumococcal polysaccharide vaccine (PPV) re-vaccination no further cases occurred in the following 2 months. No association was found between being an outbreak-associated case and age (P = 0.36), underlying comorbidities [relative risk (RR) 0.84 95% confidence interval (CI) 0.34-2.09], or prior receipt of PPV (RR 1.4, 95% CI 0.60-3.33). However, the median number of years since PPV was significantly higher for cases (n = 15, 10.2 years, range 7.3-17.9 years) than non-cases (n = 8, 7.2 years, range 6.8-12.8 years) (P = 0.045), provided evidence of waning immunity. Alternative vaccination strategies should be considered to prevent future S. pneumoniae outbreaks in institutionalized elderly populations.

Entities:  

Keywords:  Disease outbreaks; pneumococcal infections; pneumococcal polysaccharide vaccine

Mesh:

Substances:

Year:  2014        PMID: 25298247      PMCID: PMC9507245          DOI: 10.1017/S0950268814002490

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  23 in total

1.  Serotype prevalence in adults hospitalised with pneumococcal non-invasive community-acquired pneumonia.

Authors:  Thomas Bewick; Carmen Sheppard; Sonia Greenwood; Mary Slack; Caroline Trotter; Robert George; Wei Shen Lim
Journal:  Thorax       Date:  2012-02-28       Impact factor: 9.139

2.  Multilocus sequence typing directly on DNA from clinical samples and a cultured isolate to investigate linked fatal pneumococcal disease in residents of a shelter for homeless men.

Authors:  Andrew Birtles; Noel McCarthy; Carmen L Sheppard; Harry Rutter; Malcolm Guiver; Elizabeth Haworth; Robert C George
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

3.  Streptococcus pneumoniae transmission in chronic-care facilities: description of an outbreak and review of management strategies.

Authors:  D C Sheppard; K A Bartlett; H W Lampiris
Journal:  Infect Control Hosp Epidemiol       Date:  1998-11       Impact factor: 3.254

4.  Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Swedish Pneumococcal Vaccination Study Group.

Authors:  A Ortqvist; J Hedlund; L A Burman; E Elbel; M Höfer; M Leinonen; I Lindblad; B Sundelöf; M Kalin
Journal:  Lancet       Date:  1998-02-07       Impact factor: 79.321

5.  Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study.

Authors:  Elizabeth Miller; Nicholas J Andrews; Pauline A Waight; Mary Pe Slack; Robert C George
Journal:  Lancet Infect Dis       Date:  2011-05-27       Impact factor: 25.071

6.  Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial.

Authors:  Takaya Maruyama; Osamu Taguchi; Michael S Niederman; John Morser; Hiroyasu Kobayashi; Tetsu Kobayashi; Corina D'Alessandro-Gabazza; Sei Nakayama; Kimiaki Nishikubo; Takashi Noguchi; Yoshiyuki Takei; Esteban C Gabazza
Journal:  BMJ       Date:  2010-03-08

7.  Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales.

Authors:  Nick J Andrews; Pauline A Waight; Robert C George; Mary P E Slack; Elizabeth Miller
Journal:  Vaccine       Date:  2012-09-18       Impact factor: 3.641

Review 8.  Pneumococcal vaccination and revaccination of older adults.

Authors:  Andrew S Artz; William B Ershler; Dan L Longo
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

9.  An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residents.

Authors:  J P Nuorti; J C Butler; J M Crutcher; R Guevara; D Welch; P Holder; J A Elliott
Journal:  N Engl J Med       Date:  1998-06-25       Impact factor: 91.245

10.  A preventable outbreak of pneumococcal pneumonia among unvaccinated nursing home residents in New Jersey during 2001.

Authors:  Christina G Tan; Stanley Ostrawski; Eddy A Bresnitz
Journal:  Infect Control Hosp Epidemiol       Date:  2003-11       Impact factor: 3.254

View more
  6 in total

1.  Use of a serotype-specific urine immunoassay to determine the course of a hospital outbreak of Streptococcus pneumoniae complicated by influenza A.

Authors:  Carmen L Sheppard; John Clark; Mary P E Slack; Norman K Fry; Timothy G Harrison
Journal:  JMM Case Rep       Date:  2016-02-12

2.  Pneumococcal Vaccination Guidance for Post-Acute and Long-Term Care Settings: Recommendations From AMDA's Infection Advisory Committee.

Authors:  David A Nace; Laurie R Archbald-Pannone; Muhammad S Ashraf; Paul J Drinka; Elizabeth Frentzel; Swati Gaur; Dheeraj Mahajan; David R Mehr; William C Mercer; Philip D Sloane; Robin L P Jump
Journal:  J Am Med Dir Assoc       Date:  2017-02-01       Impact factor: 4.669

3.  When are pathogen genome sequences informative of transmission events?

Authors:  Finlay Campbell; Camilla Strang; Neil Ferguson; Anne Cori; Thibaut Jombart
Journal:  PLoS Pathog       Date:  2018-02-08       Impact factor: 6.823

Review 4.  Streptococcus pneumoniae outbreaks and implications for transmission and control: a systematic review.

Authors:  Paul N Zivich; John D Grabenstein; Sylvia I Becker-Dreps; David J Weber
Journal:  Pneumonia (Nathan)       Date:  2018-11-05

5.  Upper airways colonisation of Streptococcus pneumoniae in adults aged 60 years and older: A systematic review of prevalence and individual participant data meta-analysis of risk factors.

Authors:  Emma L Smith; India Wheeler; Hugh Adler; Daniela M Ferreira; Raquel Sá-Leão; Osman Abdullahi; Ifedayo Adetifa; Sylvia Becker-Dreps; Susanna Esposito; Helmia Farida; Rama Kandasamy; Grant A Mackenzie; J Pekka Nuorti; Susan Nzenze; Shabir A Madhi; Omar Ortega; Anna Roca; Dodi Safari; Frieder Schaumburg; Effua Usuf; Elisabeth A M Sanders; Lindsay R Grant; Laura L Hammitt; Katherine L O'Brien; Prabhu Gounder; Dana J T Bruden; Michelle C Stanton; Jamie Rylance
Journal:  J Infect       Date:  2020-06-17       Impact factor: 6.072

6.  A Japanese nationwide survey of 23-valent pneumococcal capsular polysaccharide vaccine (PPSV23) revaccination coverage rate among elderly adults aged 65 and older and physician's attitude.

Authors:  Atsushi Nakamura; Kenji Kawakami; Akira Wakana; Temitope A Folaranmi; Tomoharu Iino
Journal:  Hum Vaccin Immunother       Date:  2020-02-11       Impact factor: 3.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.